YourVoice.Now
Back to Dashboard
HR-3886House2025-06-10Armed Forces and National Security

Veterans PTSD Screening Act

YourVoice.Now Summary

Directs the VA to study whether a blood-based RNA test can objectively detect PTSD in veterans, reporting to Congress by 2028.

The details

Veterans with PTSD could eventually be diagnosed using a blood-based lab technique under a bill that directs the Department of Veterans Affairs to study whether RNA sequencing — a method that analyzes gene activity — can detect signs of inflammation or cellular stress linked to the condition. The study would run in medical facilities across five VA regional networks and must begin within 120 days of enactment. It would continue until September 30, 2027, and the VA would have until September 30, 2028, to report its findings to Congress. If successful, this kind of testing could give doctors a more objective way to diagnose PTSD alongside existing questionnaire-based methods. The bill does not require the VA to adopt RNA sequencing as a diagnostic tool — it only funds a study to evaluate its usefulness.

Congressional Summary

Veterans PTSD Screening ActThis bill requires the Department of Veterans Affairs (VA) to study through FY2027 whether RNA sequencing can be used to effectively diagnose veterans with inflammation or cellular stress (symptoms of post-traumatic stress disorder). The VA must submit to Congress a report on the results of the study.

Details

Congress
119th
Chamber
House
Status
summarized
Action
Introduced in House
Action Date
2025-06-10
Date Added
2026-07-19
Source
Congress.gov →

Like reading a bill in plain English?

We're building an app that does this for every bill in Congress and lets you tell your reps how you want them to vote. We're a small team getting ready to launch, and we're trying to show investors that real people want this. Be one of them. Help us get it built. Leave your email and we'll tell you the moment the app is ready.

By default, we'll only email you once — when the app launches. Unless you opt in below, you won't receive anything else. We don't share or sell your email.